Regencell director proposes $170K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Regencell Bioscience Holdings Ltd (RGC) director Wing Yan William Lo reported a proposed sale of 36,001 ordinary shares, with an aggregate market value of US$169,924.72. The proposed sale date is November 18, 2026; the value is based on the November 16, 2026 closing price of US$4.72 per share.
Lo acquired the shares on November 17, 2026 by exercising stock options under the issuer’s 2021 share option plan. Regencell had 495,884,376 ordinary shares issued and outstanding as of October 7, 2026.
Key Figures
Key Terms
aggregate market value financial
Form S-8 registration statement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.